Literature DB >> 30569659

Pediatric voiding cystourethrography: An essential examination for urologists but a terrible experience for children.

Kazuyoshi Johnin1, Kenichi Kobayashi1, Teruhiko Tsuru1, Tetsuya Yoshida1, Susumu Kageyama1, Akihiro Kawauchi1.   

Abstract

Voiding cystourethrography is the most important fluoroscopic examination in pediatric urology for the investigation of lower urogenital tract diseases, such as vesicoureteral reflux or urethral stricture. However, this invasive procedure imposes a significant burden on children and their parents, and recently there has been a paradigm shift in the diagnosis and treatment of vesicoureteral reflux. In the 2011 revision, the American Academy of Pediatrics guidelines on urinary tract infection recommended abandoning routine voiding cystourethrography after the first febrile urinary tract infection. In 2014, the randomized intervention for children with vesicoureteral reflux study recommended discontinuation of routine continuous antibiotic prophylaxis for vesicoureteral reflux. The time is now ripe to radically reconsider indications for voiding cystourethrography and the procedure itself.
© 2018 The Japanese Urological Association.

Entities:  

Keywords:  child; vesicoureteral reflux; voiding cystourethrography

Mesh:

Year:  2018        PMID: 30569659     DOI: 10.1111/iju.13881

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

Review 1.  Brazilian consensus on vesicoureteral reflux-recommendations for clinical practice.

Authors:  José Murillo Bastos; Atila Victal Rondon; Marcos Giannetti Machado; Miguel Zerati; Rodrigo Lessa Pena Nascimento; Salvador Vilar Correa Lima; Adriano de Almeida Calado; Ubirajara Barroso
Journal:  Int Braz J Urol       Date:  2020 Jul-Aug       Impact factor: 1.541

2.  Retrospective evaluation of the pediatric multicystic dysplastic kidney patients: experience of two centers from southeastern Turkey

Authors:  Mehtap Akbalık Kara; Aysel Taktak; Caner Alparslan
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.